Assembly Biosciences Inc (ASMB)
14.85
+0.13
(+0.88%)
USD |
NASDAQ |
May 17, 16:00
14.85
0.00 (0.00%)
After-Hours: 18:26
Assembly Biosciences Cash from Financing (TTM): 9.326M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 9.326M |
December 31, 2023 | 13.82M |
September 30, 2023 | 5.063M |
June 30, 2023 | 5.063M |
March 31, 2023 | 5.106M |
December 31, 2022 | 0.614M |
September 30, 2022 | 2.89M |
June 30, 2022 | 12.94M |
March 31, 2022 | 18.93M |
December 31, 2021 | 53.06M |
September 30, 2021 | 56.04M |
June 30, 2021 | 46.83M |
March 31, 2021 | 41.62M |
December 31, 2020 | 7.599M |
September 30, 2020 | 139.33M |
June 30, 2020 | 139.87M |
March 31, 2020 | 139.62M |
December 31, 2019 | 139.65M |
September 30, 2019 | 2.836M |
June 30, 2019 | 157.30M |
March 31, 2019 | 158.44M |
December 31, 2018 | 159.79M |
September 30, 2018 | 225.42M |
June 30, 2018 | 69.84M |
March 31, 2018 | 68.09M |
Date | Value |
---|---|
December 31, 2017 | 67.24M |
September 30, 2017 | 1.164M |
June 30, 2017 | 0.9011M |
March 31, 2017 | 0.793M |
December 31, 2016 | 0.153M |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.2574M |
March 31, 2016 | 10.90M |
December 31, 2015 | 81.57M |
September 30, 2015 | 96.53M |
June 30, 2015 | 96.27M |
March 31, 2015 | 85.63M |
December 31, 2014 | 16.73M |
September 30, 2014 | 1.995M |
June 30, 2014 | 5.383M |
March 31, 2014 | 5.383M |
December 31, 2013 | 24.37M |
September 30, 2013 | 24.14M |
June 30, 2013 | 20.75M |
March 31, 2013 | 25.47M |
December 31, 2012 | 4.897M |
September 30, 2012 | 4.911M |
June 30, 2012 | 50.91M |
March 31, 2012 | 46.41M |
December 31, 2011 | 47.49M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.614M
Minimum
Dec 2022
157.30M
Maximum
Jun 2019
49.87M
Average
16.37M
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.313M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.68M |
Oragenics Inc | 0.2839M |